Cigna Group Future Growth

Future criteria checks 2/6

Cigna Group is forecast to grow earnings and revenue by 9.6% and 8.1% per annum respectively. EPS is expected to grow by 13.9% per annum. Return on equity is forecast to be 17.8% in 3 years.

Key information

9.6%

Earnings growth rate

13.9%

EPS growth rate

Healthcare earnings growth	16.3%
Revenue growth rate	8.1%
Future return on equity	17.8%
Analyst coverage	Good
Last updated	12 Apr 2024

Recent future growth updates

Recent updates

Here's Why We Think The Cigna Group's (NYSE:CI) CEO Compensation Looks Fair for the time being

Apr 18

If EPS Growth Is Important To You, Cigna Group (NYSE:CI) Presents An Opportunity

Jun 18

Cigna: Buy This Value Gem Before It Bounces Back

Jun 12

Returns On Capital At Cigna Group (NYSE:CI) Paint A Concerning Picture

Jun 04

Cigna: Many Reasons To Invest

May 29

An Intrinsic Calculation For The Cigna Group (NYSE:CI) Suggests It's 49% Undervalued

May 21

Is Cigna Group (NYSE:CI) A Risky Investment?

Mar 24

Cigna Corporation: Undervalued For Stable Growth

Feb 23

Do Cigna's (NYSE:CI) Earnings Warrant Your Attention?

Feb 21

Cigna (NYSE:CI) Will Pay A Larger Dividend Than Last Year At $1.23

Feb 06

CIGNA Q4 2022 Earnings Preview

Feb 02

Cigna Corporation Is At A Great Entry Price

Jan 18

Cigna: A Defensive Stock With Multiple Avenues For Growth

Jan 11

Here's Why Cigna (NYSE:CI) Can Manage Its Debt Responsibly

Dec 21

Are Investors Undervaluing Cigna Corporation (NYSE:CI) By 45%?

Nov 27

Cigna Q3: Where I Went Wrong

Nov 07

Danger Ahead For Cigna

Oct 14

Cigna launches Pathwell suite of products

Sep 28

Earnings and Revenue Growth Forecasts

NYSE:CI - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	260,356	7,770	11,952	12,874	10
12/31/2025	245,413	7,188	12,354	11,185	16
12/31/2024	235,096	6,602	11,050	11,471	16
12/31/2023	195,187	5,164	10,240	11,813	N/A
9/30/2023	189,856	5,292	10,892	12,445	N/A
6/30/2023	186,021	6,641	11,414	12,902	N/A
3/31/2023	182,798	6,738	10,239	11,654	N/A
12/31/2022	180,031	6,704	7,361	8,656	N/A
9/30/2022	180,028	6,627	9,578	10,832	N/A
6/30/2022	179,185	5,491	8,402	9,668	N/A
3/31/2022	176,986	5,401	6,928	8,128	N/A
12/31/2021	174,267	5,370	6,037	7,191	N/A
9/30/2021	170,397	8,384	6,041	7,210	N/A
6/30/2021	167,028	8,151	4,915	5,986	N/A
3/31/2021	163,141	8,438	8,487	9,556	N/A
12/31/2020	160,550	8,458	9,256	10,350	N/A
9/30/2020	157,009	5,300	7,764	8,849	N/A
6/30/2020	154,629	5,263	9,339	10,415	N/A
3/31/2020	154,168	4,917	7,057	8,180	N/A
12/31/2019	153,743	5,104	8,435	9,485	N/A
9/30/2019	129,660	4,271	5,896	6,818	N/A
6/30/2019	102,510	3,692	4,176	4,981	N/A
3/31/2019	75,145	3,090	4,318	4,937	N/A
12/31/2018	48,569	2,637	3,242	3,770	N/A
9/30/2018	44,969	2,759	3,742	4,219	N/A
6/30/2018	44,001	2,547	4,333	4,830	N/A
3/31/2018	42,949	2,554	4,049	4,532	N/A
12/31/2017	42,043	2,237	3,615	4,086	N/A
9/30/2017	41,332	2,353	N/A	4,358	N/A
6/30/2017	40,723	2,249	N/A	5,035	N/A
3/31/2017	40,258	1,946	N/A	4,684	N/A
12/31/2016	40,007	1,867	N/A	4,026	N/A
9/30/2016	39,252	1,911	N/A	4,315	N/A
6/30/2016	38,761	2,002	N/A	3,017	N/A
3/31/2016	38,293	2,080	N/A	3,117	N/A
12/31/2015	37,876	2,094	N/A	2,933	N/A
9/30/2015	37,276	2,135	N/A	2,319	N/A
6/30/2015	36,644	2,122	N/A	2,175	N/A
3/31/2015	35,885	2,107	N/A	2,241	N/A
12/31/2014	34,914	2,102	N/A	2,158	N/A
9/30/2014	34,098	1,996	N/A	2,084	N/A
6/30/2014	33,407	2,015	N/A	2,444	N/A
3/31/2014	32,654	1,947	N/A	2,014	N/A
12/31/2013	32,380	1,476	N/A	719	N/A
9/30/2013	31,888	1,521	N/A	900	N/A
6/30/2013	31,145	1,434	N/A	-250	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CI's forecast earnings growth (9.6% per year) is above the savings rate (2.3%).

Earnings vs Market: CI's earnings (9.6% per year) are forecast to grow slower than the US market (14.7% per year).

High Growth Earnings: CI's earnings are forecast to grow, but not significantly.

Revenue vs Market: CI's revenue (8.1% per year) is forecast to grow faster than the US market (8.1% per year).

High Growth Revenue: CI's revenue (8.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: CI's Return on Equity is forecast to be low in 3 years time (17.8%).

Discover growth companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Cigna Group Future Growth

Future criteria checks 2/6

Key information

Recent future growth updates

The Cigna Group Provides Earnings Guidance for the Fiscal Year 2024

Price target increased to US$348

Consensus forecasts updated

Price target increased to US$337

Recent updates

The Cigna Group Declares Quarterly Dividend, Payable on June 20, 2024

Here's Why We Think The Cigna Group's (NYSE:CI) CEO Compensation Looks Fair for the time being

National Center for Public Files an Exempt Solicitation Statement and Request Vote for the Proposal

Cigna: Time To Sell The Stock After A 50% Return? No, Here's Why

Returns Are Gaining Momentum At Cigna Group (NYSE:CI)

Cigna Continues To Reap Gains From A Shrewd Acquisition Made In 2018

President notifies of intention to sell stock

The Cigna Group, Annual General Meeting, Apr 24, 2024

Cigna: Trimming The Fat And Staying Focused

Upcoming dividend of US$1.40 per share

Cigna: Big Buybacks And Total Return Potential

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Cigna Group (NYSE:CI) Is Increasing Its Dividend To $1.40

Third quarter dividend increased to US$1.40

Insider notifies of intention to sell stock

The Cigna Group Provides Earnings Guidance for the Fiscal Year 2024

The Cigna Group Declares Cash Quarterly Dividend, Payable on March 21, 2024

Cigna Q4 Preview: The Analysts' Whisper - Deciphering Cigna's Next Big Leap

We Think Cigna Group (NYSE:CI) Can Stay On Top Of Its Debt

the Cigna Group Announces Intention to Retire of Mary Agoglia Hoeltzel as Senior Vice President and Chief Accounting Officer, Effective from July 1, 2024

Why Dividend Growth Investors Should Buy Cigna

The Cigna Group Announces Management Changes

It's A Story Of Risk Vs Reward With The Cigna Group (NYSE:CI)

Cigna Group (NYSE:CI) Is Experiencing Growth In Returns On Capital

Cigna: Sentiment And Fundamentals On Their Side

Insider notifies of intention to sell stock

Investor sentiment improves as stock rises 17%

Cigna's Merger Fumble: A Festive Financial Rebound

Cigna Reportedly Ends Humana Merger Talks

Cigna, Humana Reportedly in Talks for Merger

Humana And Cigna Topple On Rumors Of An Unlikely Union

Cigna and Humana Reportedly in Merger Talks

Cigna Healthcare Appoints Hisham Radwan as Chief Executive Officer of Cigna Insurance Saudi Arabia

Cigna Healthcare Appoints Hisham Radwan as Chief Executive Officer of Cigna Insurance Saudi Arabia

Upcoming dividend of US$1.23 per share at 1.7% yield

The Cigna Group to Report Q2, 2024 Results on Aug 01, 2024

Cigna Delivering Growth At A Great Price

Cigna Reportedly Explores Shedding Medicare Advantage Business

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

The Cigna Group Declares Quarterly Dividend, Payable on December 21, 2023

Cigna: Too Cheap To Ignore

We Think Cigna Group (NYSE:CI) Can Stay On Top Of Its Debt

Cigna Healthcare Expands 2024 Medicare Advantage Plans Offering Customers More Variety and Value

Cigna: Buy Rating Driven By Undervaluation & Revenue Growth

Cigna Group (NYSE:CI) Is Reinvesting At Lower Rates Of Return

The Cigna Group to Report Q1, 2024 Results on May 02, 2024

Cigna: Seizing Opportunities And Managing Risks In The Healthcare Landscape

Cigna Healthcare Launches New Global Health Benefits Plan for Adults Aged 60+

Insider notifies of intention to sell stock

Upcoming dividend of US$1.23 per share at 1.8% yield

Cigna Group: Weaker Than Peers But Still A Buy

Executive VP & General Counsel notifies of intention to sell stock

Insider recently sold US$2.3m worth of stock

Insider notifies of intention to sell stock

Cigna: Buy During The Next Correction (Technical Analysis)

Second quarter 2023 earnings released: EPS: US$4.96 (vs US$4.95 in 2Q 2022)

The Cigna Group Declares Quarterly Dividend, Payable on September 21, 2023

Executive Vice President of Strategy notifies of intention to sell stock

Cigna Group (NYSE:CI) Has A Pretty Healthy Balance Sheet

Cigna: Buy While It's Still Cheap And Not Loved

The Cigna Group Announces Executive Changes

If EPS Growth Is Important To You, Cigna Group (NYSE:CI) Presents An Opportunity

Cigna: Buy This Value Gem Before It Bounces Back

Returns On Capital At Cigna Group (NYSE:CI) Paint A Concerning Picture

Upcoming dividend of US$1.23 per share at 2.0% yield

Cigna: Many Reasons To Invest

An Intrinsic Calculation For The Cigna Group (NYSE:CI) Suggests It's 49% Undervalued

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Is Cigna Group (NYSE:CI) A Risky Investment?

Executive Vice President of Strategy notifies of intention to sell stock

President notifies of intention to sell stock